The invention relates to novel 1,2,3,4-tetrahydroisoquinoline derivatives of formula (I) and related compounds and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and especially their use as neurohormonal antagonists especially urotensin II antagonists.
本发明涉及新颖的1,2,3,4-
四氢异喹啉衍
生物(I)及其相关化合物,以及它们作为制备药物组成部分的活性成分的用途。本发明还涉及相关方面,包括制备化合物的过程,含有其中一个或多个化合物的药物组成物,特别是它们作为神经激素拮抗剂,特别是尿泰松II拮抗剂的用途。